STAT

Opinion: Paging Dr. Topol: Grasping the multidimensional narrative of ‘Deep Medicine’

The medical mind has limitations — a physician can know the signs of only a fraction of the 10,000 or so human diseases. Powerful tools like AI and machine learning…

Depth is all about discovering a new dimension. When you add width to length and height, you create volume, which just happens to be a synonym for “book.” I’ve just finished Eric Topol’s latest tome, “Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again,” and was fascinated by its multidimensional narrative.

Although artificial intelligence (AI) is more than human, Topol took great pains to make “Deep Medicine” a book of human dimensions. It mimics the direction the author wants medicine to take: to become more comprehensive, personal, effective, and humane as AI improves. He goes out of his way to reveal numerous sides of himself (patient, caregiver, husband, son-in-law, father, doctor, and researcher) as a way to embody health care’s holistic future.

Topol begins by talking about his difficult experience following knee surgery. He was put on a course of vigorous physical therapy that included some anguished episodes on a stationary

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks